Test ID: 61207
IDH1/IDH2 Mutation Analysis by Pyrosequencing, Paraffin
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
61207
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Supporting a diagnosis of grade II or III astrocytoma, oligodendroglioma, oligoastrocytoma, or secondary glioblastoma
Stratifying prognosis of gliomas
Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| 60254 | AP Special Studies Review | No | Yes |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
This test is performed in conjunction with 60254 Anatomic Pathology Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 Anatomic Pathology Special Studies Review could be changed to 5439 Surgical Pathology Consultation if they determine this is more appropriate.
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) and Pyrosequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
IDH1/IDH2 Genes, Known Mutations
Aliases Lists additional common names for a test, as an aid in searching
IDH1
IDH2
Isocitrate Dehydrogenase 1
Isocitrate Dehydrogenase 2
IDH2
Isocitrate Dehydrogenase 1
Isocitrate Dehydrogenase 2
External
link
PDF
document
Excel
document
Word
document